• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Hong Kong·Consumer Cyclical·6893.HK
Share

Hin Sang Group Stocks

HK$ 0.19Last Updated 30.07.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

HK$ 24.78M

HK$ 0.19
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hin Sang Group (International) Holding Co. Ltd., founded in 1996 and headquartered in Tsim Sha Tsui, Hong Kong, functions as a subsidiary of Genwealth Group Holding Company Limited. The company's core business revolves around developing, promoting, and selling healthcare products, with a particular emphasis on offerings for children, primarily serving the markets of Hong Kong and Mainland China. Its operations are strategically organized into four principal segments: 1. Product Development: This division focuses on creating and commercializing personal care products, household goods, and health supplements under proprietary brand names such as Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic. 2. Brand Development and Management: This unit specializes in the marketing, sales, distribution, logistics, and delivery of personal care products for brands including Pahmi, Enear, Vcnic, Zici, and Sunew, while also offering brand management and development services to other brand owners. 3. Trading of Goods: This segment handles the distribution and sale of skincare, personal care, and household products, procured from diverse sources like authorized dealers, independent traders, manufacturers, parallel importers, and various suppliers. 4. Healthcare: This division provides traditional Chinese medical services tailored for mothers and children, in addition to developing maternal and child health-related products and operating medical centers and hospitals. Beyond these primary activities, the group also engages in the trade of skincare, personal care, and slimming products, as well as property holding. The company's products are available to consumers directly in Hong Kong, through a robust distribution network spanning the People's Republic of China and Macau, and via online platforms.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is 'expensive' on EV/EBITDA, overvalued on

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 03:07

Apple shares fell after a weak forecast. Sales will be affected by a shortage of memory chips

31.07.2026 02:45

It's the best day for chipmakers since 2025. Burry is shorting them again.

31.07.2026 01:43

Amazon reported accelerated revenue growth in its cloud business. Its stock jumped 9%.

31.07.2026 01:27

Microsoft Beat Nvidia's Record for Market Capitalization Growth

31.07.2026 01:08

The assets of the "AI-Nostradamus" fund fell to $10 billion following the sale of part of its portfolio

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026